Beijing, July 28th (Xinhua News Agency) (Xiao Han) - July 28th is the 13th World Hepatitis Day, and this year's promotion theme in China is "Adhere to early prevention, strengthen detection and detection, and standardize antiviral treatment". In recent years, China has made great achievements in the prevention and treatment of hepatitis, and has possessed relevant prevention and treatment technologies and capabilities. However, due to the large number of hepatitis infected people and the heavy burden of Disease burden, the prevention and treatment of hepatitis still has a long way to go. At present, the situation of hepatitis prevention and control in China is still severe, and the level of health and quality of life need to be further improved. At the recently held "World Hepatitis Day Propaganda Conference", experts attending the conference stated that viral hepatitis is a major infectious disease in China, which is related to the national economy and people's livelihood. They hope that various regions can adjust measures to local conditions, deepen the coordination and integration of medical prevention and control, and establish an integrated prevention and control system of prevention, screening, diagnosis and treatment, and management. Implement full course management gateway migration, strengthen testing, and standardize treatment to help achieve the goal of eliminating the harm of hepatitis. At the World Hepatitis Day Promotion Conference, China has the ability to intervene throughout the entire course of hepatitis. China is one of the countries with the most serious harm to viral hepatitis, and both the number of infections and the severity of the disease are major diseases that affect the health level of the Chinese people. Since the establishment of the People's Republic of China, China has adhered to the policy of putting prevention first and combining prevention and control, and has achieved great achievements. Since the 18th National Congress of the Communist Party of China, relevant prevention and control requirements have been clearly put forward in documents such as the "Healthy China 2030" Plan Outline and the "Healthy China Action (2019-2030)". "The new infection of hepatitis virus can be effectively prevented through vaccination, blood safety management, and food and drinking water hygiene. China has all the technical conditions for the whole course of prevention and treatment of viral hepatitis." Wang Yu, president of the China Hepatitis Prevention Foundation, said that it is a long-term pathological process from hepatitis B virus infection to the development of liver cancer. Chinese experts have developed active intervention strategies to prevent hepatitis related primary liver cancer, It can be prevented and treated, early detection and treatment have good effects, and intervention measures can achieve significant results. Zhuang Hui, an academician of the CAE Member, introduced that, as one of the key measures to reduce the harm of infectious diseases, screening can improve the diagnosis rate and treatment rate and reduce the harm of diseases. By screening the general population for hepatitis virus, early prevention can be achieved for those who have not yet been infected; Early diagnosis and treatment of infected individuals to prevent further disease progression. A study found that the one-time screening of HBsAg in 100000 people aged 18-69 can reduce compensatory cirrhosis, decompensated cirrhosis, liver cancer, liver transplantation and liver related deaths. This demonstrates the importance of active screening. In terms of improving the treatment rate of hepatitis B, Professor Jia Jidong, Beijing Friendship Hospital affiliated to Capital Medical University, said that China is still the country with the heaviest burden of viral hepatitis in the world, and chronic hepatitis B is an important cause of cirrhosis and liver cancer. The new version of the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (2022 Edition)" further expands the indications for antiviral treatment, reflecting a more proactive concept of antiviral treatment. Only by promoting expanded screening can patients with potential disease progression risks and in need of treatment be identified as soon as possible, and the treatment rate of the population be increased. Pay attention to the early screening, early diagnosis and early treatment of hepatitis, promote the level of prevention and treatment. In 2002, hepatitis B